Alta Partners VIII, L.P.'s Net Worth

$39.5 Million

Who is Alta Partners VIII, L.P.?

Alta Partners VIII, L.P. has an estimated net worth of $39.5 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., ANESIVA, INC., ZS Pharma, Inc., Allakos Inc., SUTRO BIOPHARMA INC, Esperion Therapeutics, Inc., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., and ATS MEDICAL INC.

SEC CIK

Alta Partners VIII, L.P.'s CIK is 0001399763

Past Insider Trading and Trends

2014 was Alta Partners VIII, L.P.'s most active year for acquiring shares with 8 total transactions. Alta Partners VIII, L.P.'s most active month to acquire stocks was the month of June. 2015 was Alta Partners VIII, L.P.'s most active year for disposing of shares, totalling 19 transactions. Alta Partners VIII, L.P.'s most active month to dispose stocks was the month of May. 2014 saw Alta Partners VIII, L.P. paying a total of $7,194,708.00 for 6,018,675 shares, this is the most they've acquired in one year. In 2015 Alta Partners VIII, L.P. cashed out on 17,055,314 shares for a total of $35,700,680.80, their largest year based on trade value.